Table 3.
Summary of enrollment viremia values of hospitalized study dengue patients (n = 208) and community-based ambulatory dengue patients (n = 189)
| Virology | Hospitalized dengue patients (n = 208) | Ambulatory dengue patients (n = 189) | Comparison (P value)* |
| Serotype: DENV-1 | |||
| Viremia, median (IQR) log10-copies/mL | 8.35 (7.44–9.02) | 7.69 (6.69–8.51) | 0.01 |
| Viremia > serotype MID50, x/n (%) | 67/78 (86) | 41/52 (79) | |
| Serotype: DENV-2 | |||
| Viremia, median (IQR) log10-copies/mL | 7.77 (6.85–8.61) | 7.25 (6.41–8.11) | 0.01 |
| Viremia > serotype MID50, x/n (%) | 74/83 (89) | 39/52 (75) | |
| Serotype: DENV-3 | |||
| Viremia, median (IQR) log10-copies/mL | 8.55 (7.57–9.21) | 6.03 (5.24–6.73) | <0.0001 |
| Viremia > serotype MID50, x/n (%) | 19/25 (76) | 2/23 (9) | |
| Serotype: DENV-4 | |||
| Viremia, median (IQR) log10-copies/mL | 6.58 (6.17–7.84) | 7.05 (5.88–7.58) | 0.07 |
| Viremia > serotype MID50, x/n (%) | 8/22 (36) | 20/62 (32) |
*
Comparison of log10-viremia between hospitalized and community patients based on linear regression with adjustment for day of illness at enrollment. IQR, interquartile range.